Success Stories: EB-1A Petition Approved in 6 Days for Postdoctoral Fellow from China in the Field of Biomedical Science (Premium Processing, No RFE)

Client’s Testimonial:

“You are welcome! I have started recommending your law firm to the colleague in my department even before we began working together. My previous case was totally messed up by the previous law firm. Your law firm has nearly covered the service for all people in my department […]. Best wishes for your business!”

On April 27^th, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Fellow in the Field of Biomedical Science (Approval Notice).

General Field: Biomedical Science

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: China

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: Texas

Approval Notice Date: April 27^th, 2016

Processing Time: 6 Days (Premium Processing Requested)

Case Summary:

A well-known postdoctoral fellow from China engaged the services of North America Immigration Law Group (WeGreneed.com) to file an EB-1A (Alien of Extraordinary Ability) petition on his behalf. Our legal team and support staff did everything we could to convince the USCIS that our client’s work is of great importance to the United States. Just 6 days after we submitted the petition on our client’s behalf, Texas Service Center granted their approval.

Premium Processing:

Such rapid adjudication was largely thanks to Premium Processing (PP). This is a paid option offered by the USCIS. By paying $1,225 more, petitioners will have action taken on their cases within 15 days instead of 4-9 months. Although PP is an excellent option for petitioners who are reluctant to wait several months, PP isn’t for everyone. Only certain EB-1, EB-2 and EB-3 visa categories get to enjoy rapid adjudication (EB-1A is one of them).

Submitting an EB-1A petition:

It is no secret that EB-1A is upheld by a very high standard of law and that it has the lowest approval rates. However, with a strong petition packet and sufficient evidence proving the importance of his work, our client’s chances of getting an approval notice were high. Here are some of the key points that we focused on in preparing our client’s EB-1A petition packet:

Professional Achievements: When we filed the case, our client had published 14 scientific articles that had collected 876 citations. He had also assessed the work of his peers on 30 occasions, which proved that his insights are highly regarded by other biomedical scientists.
Peer Support: In support of our client’s EB-1A petition, five other experts in the field of biomedical science furnished us with recommendation letters. These letters stated the importance of our client’s work not only to the field but to the nation as a whole. Here is a quote extracted from one of these letters: “He is one of the most important researchers working today, and it is in the interest of the United States and its citizens suffering from cancer that he is able to continue his research.”
Research Outcome: In order to prove to the USCIS that our client’s work is of great value to the country, we first had to understand it. We did this by carefully reviewing our client’s research summary (which he wrote and submitted to us) and concluded that his findings on cancer research and bioinformatics greatly impact the U.S. medical sector.

Becoming a permanent resident:

Now, the only thing standing between our client and permanent residence is the I-485 application. As the final step in green card proceedings, an I-485 approval means getting a green card. We wish our client well with this final step and thank him for working with us.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.